Health
Trimetazidine does not improve outcomes in patients with chronic or acute coronary syndromes – News-Medical.Net
Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress …
Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress 2020.
Angina refers to constricting pain or discomfort in the front of the chest or in the neck, jaw, shoulder, or arm due to reduced blood flow to the heart. It can occur during acute coronary syndromes (ACS) and chronic coronary syndromes…
-
General18 hours agoIran’s currency at record low as tensions run high
-
Noosa News24 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
General22 hours ago‘Market has spoken’ after US tariffs sell-off: China
-
General22 hours agoTwo groups of men evicted from Rabbitohs and Roosters NRL clash after wild brawl